123 related articles for article (PubMed ID: 228835)
1. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity.
Han T; Takita H
Cancer; 1979 Dec; 44(6):2090-8. PubMed ID: 228835
[No Abstract] [Full Text] [Related]
2. [Prognostic value of the assessment of nonspecific immunologic reactivity in lung cancer].
Porwit-Ksiazek A
Nowotwory; 1982; 32(1-2):71-80. PubMed ID: 6294626
[No Abstract] [Full Text] [Related]
3. [Immune status of patients with bronchial cancer].
Aulenbacher P; Manke HG; Drings P
Klin Wochenschr; 1987 May; 65(10):445-52. PubMed ID: 3037180
[TBL] [Abstract][Full Text] [Related]
4. [Detection of suppressor lymphocytes in the blood of oncological patients by using a 3-component lymphocyte mixed culture].
Govallo VI
Vopr Onkol; 1981; 27(9):30-6. PubMed ID: 6457445
[TBL] [Abstract][Full Text] [Related]
5. [Immunological status in small cell and squamous cell lung cancer].
Janicka G; Przylipiak M; Chyczewska E; Kowal E
Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
[No Abstract] [Full Text] [Related]
6. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
7. Predictive value of T-cell subset derangements in lung cancer.
Zabbe C; Dewitte JD; Lozach P; Clavier J; Youinou P
Med Oncol Tumor Pharmacother; 1986; 3(2):83-5. PubMed ID: 3018395
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subpopulation in primary lung cancer.
Alsabti EA; Safo MH; Shaheen A
Oncology; 1979; 36(4):176-9. PubMed ID: 224357
[TBL] [Abstract][Full Text] [Related]
9. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours.
Vose BM; Moore M
Int J Cancer; 1979 Nov; 24(5):579-85. PubMed ID: 160895
[No Abstract] [Full Text] [Related]
10. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
11. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating activated T-cells in lung cancer.
Tsuyuguchi I; Shiratsuchi H; Fukuoka M
Chest; 1986 May; 89(5):705-8. PubMed ID: 3009097
[TBL] [Abstract][Full Text] [Related]
13. Immunological monitoring and immunotherapy in carcinoma of the lung.
Weese JL; Herberman RB; Perlin E; Mills M; Heims W; Blom J; Green D; Reid J; Bellinger S; Law I; McCoy JL; Dean JH; Cannon GB; Djeu J
Int J Cancer; 1976 Dec; 18(6):739-49. PubMed ID: 186417
[TBL] [Abstract][Full Text] [Related]
14. [Active specific immunotherapy in patients with lung cancer following tumor removal].
Mosienko MD; Dorfman MV; Romashko NI
Vopr Onkol; 1987; 33(3):31-6. PubMed ID: 3494337
[TBL] [Abstract][Full Text] [Related]
15. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
16. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
17. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
[TBL] [Abstract][Full Text] [Related]
18. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
19. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
García MS; Barañao RI; Fernández O; Rumi LS
Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
[TBL] [Abstract][Full Text] [Related]
20. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]